Mitochondrial dysfunction in early life resulted from perinatal bisphenol A exposure contributes to hepatic steatosis in rat offspring

Toxicology Letters

Volumn 228, Issue 2, 2014, Pages 85-92

  Jiang, Ying ^a   Xia, Wei ^a   Zhu, Yingshuang ^a   Li, Xiaocui ^a   Wang, Danqi ^a   Liu, Juan ^a   Chang, Huailong ^a   Li, Gengqi ^a   Xu, Bing ^a   Chen, Xi ^a   Li, Yuanyuan ^a   Xu, Shunqing ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Bisphenol A; Early life; Mitochondria dysfunction; Nonalcoholic fatty liver disease; Reactive oxygen species

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; CYTOCHROME C; FAT DROPLET; FATTY ACID; REACTIVE OXYGEN METABOLITE; TRANSCRIPTOME;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CHEMICAL ANALYSIS; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EXPOSURE; FATTY ACID METABOLISM; FATTY ACID TRANSPORT; FATTY LIVER; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; LIPID LIVER LEVEL; LIPOGENESIS; LIVER HISTOLOGY; LIVER MITOCHONDRION; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATORY COMPLEX; MITOCHONDRION; NONHUMAN; PERINATAL EXPOSURE; PERINATAL PERIOD; PRIORITY JOURNAL; PROGENY; PROTEIN SECRETION; RAT; TRANSCRIPTOMICS;

BISPHENOL A; EARLY-LIFE; MITOCHONDRIA DYSFUNCTION; NONALCOHOLIC FATTY LIVER DISEASE; REACTIVE OXYGEN SPECIES;

ADENOSINE TRIPHOSPHATE; ANIMALS; BENZHYDRYL COMPOUNDS; BLOTTING, WESTERN; BODY WEIGHT; CYTOCHROMES C; CYTOSOL; FATTY ACIDS, NONESTERIFIED; FATTY LIVER; FEMALE; HEPATOCYTES; LIPIDS; LIVER; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIAL DISEASES; PHENOLS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; REAL-TIME POLYMERASE CHAIN REACTION; TRIGLYCERIDES;

EID: 84901002991     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2014.04.013     Document Type: Article

References (47)

1. Bailey S.M., Cunningham C.C. Contribution of mitochondria to oxidative stress associated with alcoholic liver disease. Free Radic. Biol. Med. 2002, 32:11-16.
2. Begriche K., Igoudjil A., Pessayre D., Fromenty B. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 2006, 6:1-28.
3. Begriche K., Massart J., Robin M.A., Borgne-Sanchez A., Fromenty B. Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver. J. Hepatol. 2011, 54:773-794.
4. Brown G.C. Control of respiration and ATP synthesis in mammalian mitochondria and cells. Biochem. J. 1992, 284(Pt 1):1-13.
5. Browning J.D., Szczepaniak L.S., Dobbins R., Nuremberg P., Horton J.D., Cohen J.C., Grundy S.M., Hobbs H.H. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004, 40:1387-1395.
6. Bruce K.D., Cagampang F.R., Argenton M., Zhang J., Ethirajan P.L., Burdge G.C., Bateman A.C., Clough G.F., Poston L., Hanson M.A., McConnell J.M., Byrne C.D. Maternal high-fat feeding primes steatohepatitis in adult mice offspring, involving mitochondrial dysfunction and altered lipogenesis gene expression. Hepatology 2009, 50:1796-1808.
7. Bruce K.D., Hanson M.A. The developmental origins, mechanisms, and implications of metabolic syndrome. J. Nutr. 2010, 140:648-652.
8. Chiarelli F., Marcovecchio M.L. Insulin resistance and obesity in childhood. Eur. J. Endocrinol. 2008, 159(Suppl. 1):S67L 74.
9. Cotney J., McKay S.E., Shadel G.S. Elucidation of separate, but collaborative functions of the rRNA methyltransferase-related human mitochondrial transcription factors B1 and B2 in mitochondrial biogenesis reveals new insight into maternally inherited deafness. Hum. Mol. Genet. 2009, 18:2670-2682.
10. Dillin A., Hsu A.L., Arantes-Oliveira N., Lehrer-Graiwer J., Hsin H., Fraser A.G., Kamath R.S., Ahringer J., Kenyon C. Rates of behavior and aging specified by mitochondrial function during development. Science 2002, 298:2398-2401.
11. Festing M.F., Altman D.G. Guidelines for the design and statistical analysis of experiments using laboratory animals. ILAR J./National Research Council, Institute of Laboratory Animal Resources 2002, 43:244-258.
12. Gregory R.B., Berry M.N. On the thyroid hormone-induced increase in respiratory capacity of isolated rat hepatocytes. Biochim. Biophys. Acta 1991, 1098:61-67.
13. Grun F., Blumberg B. Endocrine disrupters as obesogens. Mol. Cell Endocrinol. 2009, 304:19-29.
14. Guicciardi M.E., Gores G.J. Apoptosis: a mechanism of acute and chronic liver injury. Gut 2005, 54:1024-1033.
15. Guthrie H.D., Welch G.R. Determination of high mitochondrial membrane potential in spermatozoa loaded with the mitochondrial probe 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolyl-carbocyanine iodide (JC-1) by using fluorescence-activated flow cytometry. Methods Mol. Biol. (Clifton, NJ) 2008, 477:89-97.
16. Houstis N., Rosen E.D., Lander E.S. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006, 440:944-948.
17. Huc L., Lemarie A., Gueraud F., Helies-Toussaint C. Low concentrations of bisphenol A induce lipid accumulation mediated by the production of reactive oxygen species in the mitochondria of HepG2 cells. Toxicol. In Vitro 2012, 26:709-717.
18. Kazantzis M., Stahl A. Fatty acid transport proteins, implications in physiology and disease. Biochim. Biophys. Acta 2012, 1821:852-857.
19. Kleiner D.E., Brunt E.M., Van Natta M., Behling C., Contos M.J., Cummings O.W., Ferrell L.D., Liu Y.C., Torbenson M.S., Unalp-Arida A., Yeh M., McCullough A.J., Sanyal A.J. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41:1313-1321.
20. Kluck R.M., Bossy-Wetzel E., Green D.R., Newmeyer D.D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997, 275:1132-1136.
21. Lang I.A., Galloway T.S., Scarlett A., Henley W.E., Depledge M., Wallace R.B., Melzer D. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 2008, 300:1303-1310.
22. Leung C.H., Wang L., Fu Y.Y., Yuen W., Caldarone C.A. Transient mitochondrial permeability transition pore opening after neonatal cardioplegic arrest. J. Thorac. Cardiovasc. Surg. 2011, 141:975-982.
23. Li Z., Berk M., McIntyre T.M., Gores G.J., Feldstein A.E. The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity. Hepatology 2008, 47:1495-1503.
24. Liquori G.E., Calamita G., Cascella D., Mastrodonato M., Portincasa P., Ferri D. An innovative methodology for the automated morphometric and quantitative estimation of liver steatosis. Histol. Histopathol. 2009, 24:49-60.
25. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
26. Marmugi A., Ducheix S., Lasserre F., Polizzi A., Paris A., Priymenko N., Bertrand-Michel J., Pineau T., Guillou H., Martin P.G., Mselli-Lakhal L. Low doses of bisphenol A induce gene expression related to lipid synthesis and trigger triglyceride accumulation in adult mouse liver. Hepatology 2012, 55:395-407.
27. Min H.K., Kapoor A., Fuchs M., Mirshahi F., Zhou H., Maher J., Kellum J., Warnick R., Contos M.J., Sanyal A.J. Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease. Cell Metab. 2012, 15:665-674.
28. Miyawaki J., Sakayama K., Kato H., Yamamoto H., Masuno H. Perinatal and postnatal exposure to bisphenol a increases adipose tissue mass and serum cholesterol level in mice. J. Atheroscler. Thromb. 2007, 14:245-252.
29. Monje L., Varayoud J., Munoz-de-Toro M., Luque E.H., Ramos J.G. Neonatal exposure to bisphenol A alters estrogen-dependent mechanisms governing sexual behavior in the adult female rat. Reprod. Toxicol. 2009, 28:435-442.
30. Patrick-Melin A.J., Kalinski M.I., Kelly K.R., Haus J.M., Solomon T.P., Kirwan J.P. Nonalcoholic fatty liver disease: biochemical and therapeutic considerations. Ukr. Biokhim. Zh. 2009, 81:16-25.
31. Perez-Carreras M., Del Hoyo P., Martin M.A., Rubio J.C., Martin A., Castellano G., Colina F., Arenas J., Solis-Herruzo J.A. Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology 2003, 38:999-1007.
32. Putignani L., Raffa S., Pescosolido R., Rizza T., Del Chierico F., Leone L., Aimati L., Signore F., Carrozzo R., Callea F., Torrisi M.R., Grammatico P. Preliminary evidences on mitochondrial injury and impaired oxidative metabolism in breast cancer. Mitochondrion 2012, 12:363-369.
33. Rector R.S., Thyfault J.P., Uptergrove G.M., Morris E.M., Naples S.P., Borengasser S.J., Mikus C.R., Laye M.J., Laughlin M.H., Booth F.W., Ibdah J.A. Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model. J. Hepatol. 2010, 52:727-736.
34. Richter C.A., Birnbaum L.S., Farabollini F., Newbold R.R., Rubin B.S., Talsness C.E., Vandenbergh J.G., Walser-Kuntz D.R., vom Saal F.S. In vivo effects of bisphenol A in laboratory rodent studies. Reprod. Toxicol. 2007, 24:199-224.
35. Ryan E.A. Hormones and insulin resistance during pregnancy. Lancet 2003, 362:1777-1778.
36. Salvioli S., Ardizzoni A., Franceschi C., Cossarizza A. JC-1, but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess delta psi changes in intact cells: implications for studies on mitochondrial functionality during apoptosis. FEBS Lett. 1997, 411:77-82.
37. Selevan S.G., Kimmel C.A., Mendola P. Identifying critical windows of exposure for children's health. Environ. Health Perspect. 2000, 108(Suppl. 3):451-455.
38. Serviddio G., Bellanti F., Vendemiale G. Free radical biology for medicine: learning from nonalcoholic fatty liver disease. Free Radic. Biol. Med. 2013, 65C:952-968.
39. Shankar A., Teppala S. Urinary bisphenol A and hypertension in a multiethnic sample of US adults. J. Environ. Public Health 2012, 2012:481641.
40. Somm E., Schwitzgebel V.M., Toulotte A., Cederroth C.R., Combescure C., Nef S., Aubert M.L., Huppi P.S. Perinatal exposure to bisphenol a alters early adipogenesis in the rat. Environ. Health Perspect. 2009, 117:1549-1555.
41. Soper J.W., Pedersen P.L. Isolation of an oligomycin-sensitive ATPase complex from rat liver mitochondria. Methods Enzymol. 1979, 55:328-333.
42. Vandenberg L.N., Hauser R., Marcus M., Olea N., Welshons W.V. Human exposure to bisphenol A (BPA). Reprod. Toxicol. 2007, 24:139-177.
43. Vega-Nunez E., Alvarez A.M., Menendez-Hurtado A., Santos A., Perez-Castillo A. Neuronal mitochondrial morphology and transmembrane potential are severely altered by hypothyroidism during rat brain development. Endocrinology 1997, 138:3771-3778.
44. Wei J., Lin Y., Li Y., Ying C., Chen J., Song L., Zhou Z., Lv Z., Xia W., Chen X., Xu S. Perinatal exposure to bisphenol A at reference dose predisposes offspring to metabolic syndrome in adult rats on a high-fat diet. Endocrinology 2011, 152:3049-3061.
45. Westbrook D.G., Anderson P.G., Pinkerton K.E., Ballinger S.W. Perinatal tobacco smoke exposure increases vascular oxidative stress and mitochondrial damage in non-human primates. Cardiovasc. Toxicol. 2010, 10:216-226.
46. Yamada H., Furuta I., Kato E.H., Kataoka S., Usuki Y., Kobashi G., Sata F., Kishi R., Fujimoto S. Maternal serum and amniotic fluid bisphenol A concentrations in the early second trimester. Reprod. Toxicol. 2002, 16:735-739.
47. Zhou L., Yu X., Meng Q., Li H., Niu C., Jiang Y., Cai Y., Li M., Li Q., An C., Shu L., Chen A., Su H., Tang Y., Yin S., Raschke S., Eckardt K., Eckel J., Yang Z. Resistin reduces mitochondria and induces hepatic steatosis in mice by the protein kinase C/protein kinase G/p65/PPAR gamma coactivator 1 alpha pathway. Hepatology 2013, 57:1384-1393.